3 November 2017

Bloomberg: Patient Deaths Show Darker Side of Modernized Chinese Medicine

What killed Wu was later described in an autopsy report as a "drug allergy." But doctors couldn’t pinpoint what he was allergic to because the shots he was given contained dozens, if not hundreds, of different compounds extracted from two herbs. [...]

Chinese medicine injections generated sales of $13 billion last year, according to the research firm Forward Industries Institute. Listed companies worth billions of dollars have thrived, benefiting major global funds like those managed by Schroders Plc., UBS Group AG and Skagen AS that hold their stocks.

Yet, the industry’s ascent has also raised public health concerns. Over a hundred injections based on traditional recipes are sold in China these days, some without stringent human trials. Doctors often prescribe them in an array of untested combinations. Adverse reactions, from skin rashes to fatalities like Wu’s, doubled to about 133,000 last year from 2011, according to government data. [...]

Still, due to the history of lax regulation, many injectables based on Chinese medicine haven’t been evaluated in strict scientific clinical trials. That means the reactions they set off in the body aren’t fully known. Chinese medicine is based on centuries of practical experience. But it is traditionally taken orally, which gives the digestive system a chance to shield patients from harmful chemicals. Injecting the concoctions into the bloodstream can heighten side effects.

No comments:

Post a Comment